Study in support of the evaluation and impact assessment of the EU general pharmaceutical legislation

In 2022, Exon Consultancy collaborated with Utrecht University to support the evaluation of the EU pharmaceutical legislation. The work resulted in an analytical report presenting secondary quantitative data analysis that was carried out as part of the the study in support of the Evaluation and Impact Assessment of the EU general pharmaceutical legislation.

This project involved empirical analyses around various macroeconomic, environmental, social and technological indicators that may have been affected by the legislation, as well as in-depth case studies and contributing analysis to inform the first substantive revision of the general pharmaceutical legislation in more than 20 years.

More information about the project can be found here.

Client:
Utrecht University

Date of completion:
2022